Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

D-Wave Quantum Redeems All Public Warrants

D-Wave Quantum Inc. has completed the redemption of all outstanding public warrants to purchase shares of the company's common stock. Of the warrants that were outstanding prior to the redemption announcement, 4,746,358 warrants were exercised for approximately 6.9 million shares of common stock at an exercise price of $11.50 per warrant, generating around $54.6 million in cash proceeds for the company.

Following the redemption, a total of 270,820 warrants remained unexercised and were then redeemed for a total redemption price of $2,708.20, in accordance with the terms of the company's warrant agreement. As a result, no warrants are now outstanding.

In connection with the redemption, the warrants have ceased trading on the New York Stock Exchange (NYSE) and have been delisted, with the trading suspension effective on November 18, 2025. However, the company's common stock continues to trade on the NYSE under the symbol "QBTS."

It's worth noting that the company's quantum computers, which are the world's largest, feature QPUs with sub-second response times and can be deployed on-premises or accessed through their quantum cloud service, which offers 99.9% availability and uptime. With over 200 million problems submitted to their quantum systems to date, D-Wave Quantum Inc. has over 100 organizations trusting them with their toughest computational challenges.

The market has reacted to these announcements by moving the company's shares -12.5% to a price of $20.51. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS